Your browser doesn't support javascript.
loading
The effect of a treatment delay on outcome in metastatic renal cell carcinoma.
Iacovelli, Roberto; Galli, Luca; De Giorgi, Ugo; Porta, Camillo; Nolè, Franco; Zucali, Paolo; Sabbatini, Roberto; Mosca, Alessandra; Atzori, Francesco; Santini, Daniele; Facchini, Gaetano; Fornarini, Giuseppe; Buti, Sebastiano; Massari, Francesco; Masini, Cristina; Ricotta, Riccardo; Biasco, Elisa; Lolli, Cristian; Gri, Nicole; Verri, Elena; Miggiano, Chiara; Vitale, Maria Giuseppa; Tortora, Giampaolo.
Afiliação
  • Iacovelli R; Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy. Electronic address: roberto.iacovelli@alice.it.
  • Galli L; Medical Oncology 2, AOUP, Istituto Toscano Tumori, Pisa, Italy.
  • De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Porta C; Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.
  • Nolè F; Medical Oncology Division of Urogenital and Head & Neck Tumours, European Institute of Oncology, Milan, Italy.
  • Zucali P; Humanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano, Milano, Italy.
  • Sabbatini R; Department of Oncology and Haematology and Respiratory Disease, University Hospital, Modena, Italy.
  • Mosca A; Medical Oncology Unit, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.
  • Atzori F; Medical Oncology Unit, Azienda Ospedaliero Universitaria of Cagliari, Cagliari, Italy.
  • Santini D; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Facchini G; Departmental Unit of Clinical and Experimental Uro-Andrologic Oncology, Istituto Nazionale Tumori - Irccs - Fondazione G. Pascale, Napoli, Italy.
  • Fornarini G; Medical Oncology Department, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Italy.
  • Massari F; Division of Oncology, S.Orsola-Malpighi Hospital, Bologna, Italy.
  • Masini C; Medical Oncology Unit, Arcispedale Santa Maria Nuova, IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Ricotta R; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Biasco E; Medical Oncology 2, AOUP, Istituto Toscano Tumori, Pisa, Italy.
  • Lolli C; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Gri N; Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.
  • Verri E; Medical Oncology Division of Urogenital and Head & Neck Tumours, European Institute of Oncology, Milan, Italy.
  • Miggiano C; Humanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano, Milano, Italy.
  • Vitale MG; Department of Oncology and Haematology and Respiratory Disease, University Hospital, Modena, Italy.
  • Tortora G; Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Urol Oncol ; 37(8): 529.e1-529.e7, 2019 08.
Article em En | MEDLINE | ID: mdl-30935843

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article